At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Welcome to the AAA Annual Convention 2026
Welcome to the first day of AAA 2026! Today marks the official kickoff of four days of education, networking, innovation, and community. With sessions spanning…
Spontaneous Recovery from Radiation Induced Unilateral Profound SNHL
Sensorineural hearing loss (SNHL) is a well-known side effect of radiation therapy for the treatment of cancerous cells or to shrink a mass before surgery. …
Academy Recognizes Winter 2026 Distinguished Fellows of the American Academy of Audiology (DFAAA)
The American Academy of Audiology is proud to announce the winter 2026 class of Distinguished Fellows of the American Academy of Audiology (DFAAA), a prestigious…


